- Long-acting cabotegravir (CAB-LA) is a two-monthly jab that can prevent HIV infections through sex. It virtually nullifies people’s chances of contracting the virus and it’s more effective than the daily prevention pill that’s currently available in South Africa.
- Who is this injection for? Anyone who’s worried about contracting the virus. But young African women (among whom new infections are highest) stand to benefit the most because the jab eliminates the stress of taking a pill every day.
- For this World Aids Day edition of Bhekisisa’s television show Health Beat, we speak to CAB-LA’s manufacturer (ViiV), the scientists who’ve been testing it and the first women in the country to use the jab.
This story was produced by the Bhekisisa Centre for Health Journalism. Sign up for the newsletter.
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.